Malvern, Pa.,- Siemens Healthcare announces the availability of the 2.0 release of its ACUSON S2000 ultrasound system, a premium performance platform that features powerful imaging performance and penetrating insights to achieve sound diagnosis. The multi-specialty system offers advanced applications, such as Virtual Touch HD* technology, the second generation implementation of Acoustic Radiation Forced Impulse (ARFI)* imaging, as well as Cadence contrast agent technology** and the most comprehensive 3D/4D imaging capabilities to provide penetrating insight into complex anatomy.
The ACUSON S2000 system represents the pinnacle of innovative technology, workflow-enhancing clinical applications, and state-of-the-art ergonomic design. Covering the entire continuum of care from screening to diagnosis to therapy and follow-up, the new ACUSON S2000 ultrasound system features applications across general imaging, including obstetrics and gynecology (OB/GYN), as well as vascular and cardiac imaging.
Next Generation Tissue Strain Analytics Similar to a physical palpation exam, tissue strain analytics adds an independent parameter to the existing morphological diagnostic process by interrogating and measuring the mechanical strain properties or stiffness of tissue often correlated with pathology. Siemens implementation of ARFI, Virtual Touch Tissue Imaging and Virtual Touch Tissue Quantification, have been further optimized on the ACUSON S2000 2.0
Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
ultrasound system to perform in high definition (HD).
With Virtual Touch HD technology, we have introduced our second generation of tissue strain imaging which offers even greater sensitivity and accuracy, said Dr. Norbert Gaus, CEO, Ultrasound, Siemens Healthcare. It allows the clinician to confidently obtain accurate quantification of lesion tissue stiffness, further enhancing diagnostic confidence.
Virtual Touch Tissue Quantification is the first and only application to provide a numerical value related to tissue stiffness at a precise anatomical location, which is highly promising in identifying early stages of liver diseases causing cirrhosis. In combination with the new 9L4 transducer, the technology provides increased flexibility to encompass a broader range of imaging.
The system also integrates enhanced functionality of eSie Touch elasticity imaging, which is available on linear, curved, and endocavity transducers. A new Strain Ratio calculates the average ratio of strain within two user-selected regions of interest to allow a comparative measure for a more informed diagnosis. New color maps offer more options for viewing elastograms.
